Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | AMGN | BMY | GILD | VRTX |
| Company | Lexicon Pharmaceutcl | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.5900 | 273.45 | 47.39 | 67.47 | 402.44 |
| High | 1.5900 | 274.35 | 47.50 | 67.90 | 403.88 |
| Low | 1.5200 | 267.24 | 44.37 | 65.23 | 393.00 |
| Last | 1.5400 | 270.58 | 44.83 | 65.22 | 398.48 |
| Change | -0.0600 | -2.43 | -4.03 | -1.86 | -2.28 |
| % Change | -3.75% | -0.89% | -8.25% | -2.77% | -0.57% |
| Volume | 1,274,214 | 964,358 | 35,526,451 | 8,193,415 | 508,834 |
| 20-Day Average Volume | 2,966,441 | 2,105,513 | 12,268,431 | 6,493,125 | 948,876 |
| Previous Close | 1.6000 | 273.01 | 48.86 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 270.72 | 49.93 | 68.68 | 402.33 |
| 20-Day Raw Stochastic | 2.11% | 32.17% | 1.29% | 0.23% | 23.57% |
| 20-Day Relative Strength | 36.71% | 45.04% | 27.89% | 28.34% | 43.01% |
| Weighted Alpha | -54.02 | +9.27 | -35.17 | -23.72 | +15.06 |
| Today's Opinion | 24% Sell | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 8% Sell | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 64% Buy | 24% Buy | 8% Sell | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.52% since 04/18/24 | +2.63% since 04/18/24 | -7.87% since 04/18/24 | -1.33% since 04/18/24 | +1.20% since 04/18/24 |
| Low | 1.5200 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.26 on 04/25/24 | 391.25 on 04/19/24 |
| High | 1.8575 on 04/22/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -27.36% since 03/25/24 | -3.98% since 03/25/24 | -14.83% since 03/25/24 | -10.06% since 03/25/24 | -4.29% since 03/25/24 |
| Low | 1.5200 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.26 on 04/25/24 | 391.01 on 04/18/24 |
| High | 2.4700 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -13.48% since 01/25/24 | -13.09% since 01/25/24 | -10.30% since 01/25/24 | -18.63% since 01/25/24 | -7.39% since 01/25/24 |
| Low | 1.5200 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.26 on 04/25/24 | 391.01 on 04/18/24 |
| High | 3.7300 on 02/16/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +35.68% since 10/25/23 | -0.92% since 10/25/23 | -21.39% since 10/25/23 | -16.72% since 10/25/23 | +9.68% since 10/25/23 |
| Low | 0.9200 on 11/10/23 | 249.70 on 10/31/23 | 44.37 on 04/25/24 | 65.26 on 04/25/24 | 341.90 on 11/16/23 |
| High | 3.7300 on 02/16/24 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 393,979 | 146,436,016 | 99,027,448 | 83,519,768 | 103,580,040 |
| Shares Outstanding, K | 246,237 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 1,200,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -177,120,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 700,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -49,760,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.27 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 03/11/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 6.53 | 9.97 | 30.13 |